Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug could save legs from amputation in artery disease patients

NCT ID NCT07352800

First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 17 times

Summary

This study tests a new medicine called APAC that helps prevent blood clots in people with blocked leg arteries. It includes up to 42 adults aged 45-85 with severe disease, some of whom will have a procedure to restore blood flow. The goal is to see if APAC is safe and find the best dose, with participants followed for up to 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Helsinki University Hospital

    RECRUITING

    Helsinki, 00290, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tampere University Hospital

    RECRUITING

    Tampere, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Turku University Hospital

    RECRUITING

    Turku, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.